What You Should Know:
– Precision Medicine company Tempus announced the launch of Tempus+, a program connecting medical centers across the U.S. like Stanford Cancer Center, Baylor College of Medicine, Rush University Medical Center, and UCLA Jonsson Comprehensive Cancer Center, to advance cancer research and provide access to Tempus’ library of more than five million de-identified research records.
– Tempus’ data library and data analytics platform, Lens, can now be used by researchers to identify patterns, test hypotheses, investigate and publish their findings. Participating medical institutions can also connect with one another to further joint research endeavors.
– For example, Tempus has one of the largest comprehensive molecular profiling databases of sarcoma, across all disease subtypes and age ranges. UCLA pediatric sarcoma researchers are using Tempus+ to inform their studies and the future of clinical care.
